Jonathan Edelman is a seasoned physician and pharmaceutical executive currently serving as the Senior Vice President of the Vaccines Innovation Unit at CSL R&D since 2022. With extensive experience in strategic clinical research and regulatory affairs, they have previously held pivotal roles including Global Clinical TA Head and Vice President of Clinical Development at CSL from 2011 to 2016, and Executive Director at Merck from 2000 to 2006. Jonathan's work has involved implementing development strategies, shaping clinical research, and fostering scientific collaboration, alongside a commitment to organizational redesign for improved efficiency. They received an M.D. from the Icahn School of Medicine at Mount Sinai and completed fellowships at the Hospital of the University of Pennsylvania.
This person is not in any teams
This person is not in any offices